Authors:
Oldenburg, J
Kriz, K
Wuillemin, WA
Maly, FE
von Felten, A
Siegemund, A
Keeling, DM
Baker, P
Chu, K
Konkle, BA
Lammle, B
Albert, T
Citation: J. Oldenburg et al., Genetic predisposition to bleeding during oral anticoagulant therapy: Evidence for common founder mutations (FIXVal-10 and FIXThr-10) and an independent CpG hotspot mutation (FIXThr-10), THROMB HAEM, 85(3), 2001, pp. 454-457
Authors:
Bestmann, L
Zuger, M
Oldenburg, J
Buhler, D
Maly, FE
Citation: L. Bestmann et al., Coagulation factor IX propeptide mutations causing coumarin hypersensitivity: Identification of female Alanine-10 valine heterozygotes, THROMB HAEM, 85(3), 2001, pp. 567-568
Authors:
Ivaskevicius, V
Jurgutis, R
Rost, S
Muller, A
Schmitt, C
Wulff, K
Herrmann, FH
Muller, CR
Schwaab, R
Oldenburg, J
Citation: V. Ivaskevicius et al., Lithuanian haemophilia A and B registry comprising phenotypic and genotypic data, BR J HAEM, 112(4), 2001, pp. 1062-1070
Authors:
Schneppenheim, R
Budde, U
Obser, T
Brassard, J
Mainusch, K
Ruggeri, ZM
Schneppenheim, S
Schwaab, R
Oldenburg, J
Citation: R. Schneppenheim et al., Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease, BLOOD, 97(7), 2001, pp. 2059-2066
Authors:
Oldenburg, J
von Brederlow, B
Fregin, A
Rost, S
Wolz, W
Eberl, W
Eber, S
Lenz, E
Schwabb, R
Brackmann, HH
Effenberger, W
Harbrecht, U
Schurgers, LJ
Vermeer, C
Muller, CR
Citation: J. Oldenburg et al., Congenital deficiency of vitamin K dependent coagulation factors in two families presents as a genetic defect of the vitamin K-epoxide-reductase-complex, THROMB HAEM, 84(6), 2000, pp. 937-941
Authors:
Schwaab, R
Oldenburg, J
Kemball-Cook, G
Albert, T
Juhler, C
Hanfland, P
Ingerslev, J
Citation: R. Schwaab et al., Assay discrepancy in mild haemophilia A due to a factor VIII missense mutation (Asn694Ile) in a large Danish family, BR J HAEM, 109(3), 2000, pp. 523-528
Authors:
Oldenburg, J
Rost, S
El-Maarri, O
Leuer, M
Olek, K
Muller, CR
Schwaab, R
Citation: J. Oldenburg et al., De novo factor VIII gene intron 22 inversion in a female carrier presents as a somatic mosaicism, BLOOD, 96(8), 2000, pp. 2805-2806
Authors:
Oldenburg, J
Rost, S
El-Maarri, O
Leuer, M
Olek, K
Muller, CR
Schwaab, R
Citation: J. Oldenburg et al., De novo factor VIII gene intron 22 inversion in a female carrier presents as a somatic mosaicism, BLOOD, 96(8), 2000, pp. 2905-2906
Authors:
Haack, A
Schmitt, C
Poller, W
Oldenburg, J
Hanfland, P
Brackmann, HH
Schwaab, R
Citation: A. Haack et al., Analysis of expression kinetics and activity of a new B-domain truncated and full-length FVIII protein in three different cell lines, ANN HEMATOL, 78(3), 1999, pp. 111-116
Authors:
Lenz, E
Repas-Humpe, M
Oldenburg, J
Kreuz, W
Schroter, W
Eber, SW
Citation: E. Lenz et al., Therapy-resistant haemarthros in a patient with factor VIII inhibitor: successful treatment with recombinant factor VIIa, EUR J PED, 158(11), 1999, pp. 951-952
Authors:
Ehrenreich, H
Oldenburg, J
Hasselblatt, M
Herms, J
Dembowski, C
Loffler, BM
Bruck, W
Kamrowski-Kruck, H
Gall, S
Siren, AL
Schilling, L
Citation: H. Ehrenreich et al., Endothelin B receptor-deficient rats as a subtraction model to study the cerebral endothelin system, NEUROSCIENC, 91(3), 1999, pp. 1067-1075
Citation: J. Oldenburg et al., Induction of immune tolerance in haemophilia A inhibitor patients by the 'Bonn protocol': Predictive parameter for therapy duration and outcome, VOX SANGUIN, 77, 1999, pp. 49-54
Authors:
Ehrenreich, H
Loffler, BM
Hasselblatt, M
Langen, H
Oldenburg, J
Subkowski, T
Schilling, L
Siren, AL
Citation: H. Ehrenreich et al., Endothelin converting enzyme activity in primary rat astrocytes is modulated by endothelin B receptors, BIOC BIOP R, 261(1), 1999, pp. 149-155